BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2191212)

  • 1. [Visceral leishmaniasis contracted in Europe (kala-azar)].
    Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
    Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic problems of kala azar in non-endemic area.
    Datta U; Gupta S; Arora S; Sehgal S
    Indian J Pathol Microbiol; 1987 Jan; 30(1):23-9. PubMed ID: 3315993
    [No Abstract]   [Full Text] [Related]  

  • 3. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
    Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
    J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of serological tests in Indian kala-azar.
    Sinha R; Sehgal S
    J Trop Med Hyg; 1994 Dec; 97(6):333-40. PubMed ID: 7966534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.
    Muazzam N; Rahman KM; Miah RA; Asna SM
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):77-81. PubMed ID: 1303085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of kala-azar by rK39 dipstick assay].
    Ma Y; Hu XS; Chang KP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):252. PubMed ID: 12567678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of prevalent status of kala-azar in endemic area of Hubei Province].
    Gui AF; Zuo SL; Wu JH; Gui XE; Hu LQ; Yang LD; Zhang SQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):170-2. PubMed ID: 12567700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kala-azar acquired in Croatia].
    Wenzl H; Petritsch W; Decrinis M; Schreiber F; Warnkross H; Pristautz H; Krejs GJ
    Wien Klin Wochenschr; 1992; 104(24):757-60. PubMed ID: 1337639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases.
    Dutta GD; Dutta GP
    J Commun Dis; 1985; 17(1 Suppl):77-82. PubMed ID: 3831071
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid accurate field diagnosis of Indian visceral leishmaniasis.
    Sundar S; Reed SG; Singh VP; Kumar PC; Murray HW
    Lancet; 1998 Feb; 351(9102):563-5. PubMed ID: 9492776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodiagnosis of Kala-azar by ELISA using intact promastigote.
    Mittal V; Sehgal S; Singh VK
    J Commun Dis; 1988 Dec; 20(4):321-6. PubMed ID: 3268597
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visceral leishmaniasis in Cameroon. Seroepidemiologic survey in the Kousseri region, north Cameroon].
    Dondji B; Dereure J; Poste B; Same-Ekobo A; Dedet JP
    Bull Soc Pathol Exot; 2001 Dec; 94(5):418-20. PubMed ID: 11889946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.